🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an 8-week, double-blind, randomized placebo-controlled trial of the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-04-18
Trial ID
NCT05262270
The aim of this study is to investigate the safety and effectiveness of bup...
Status
Completed
Location
UCLA Integrated Substance Abuse Programs (ISAP)
Start Date
2011-09
Trial ID
NCT01402492
Treatments Being Tested
Dexmedetomidine is a highly selective α2 adrenoreceptor agonist approved by...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01517932
Treatments Being Tested
Serum levels of isolated anti-thyroperoxidase (TPOab) and anti-thyreoglobul...
Status
Completed
Location
Azienda ospedaliero-universitaria Careggi
Start Date
2012-04
Trial ID
NCT01465867
Treatments Being Tested
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested
This is a phase III multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-03-01
Trial ID
NCT01328444
This is a phase III multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-03-16
Trial ID
NCT01323660
This study investigates the effects of two hormones called epinephrine and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-12
Trial ID
NCT04148261
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Vince & Associates
Start Date
2016-07
Trial ID
NCT02856854
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Chidami...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2013-04
Trial ID
NCT01836679
Treatments Being Tested